Risk factors for progression to treatment among 48 patients with SWM
| Multivariate model . | Hazard ratio . | P . |
|---|---|---|
| Bone marrow lymphoplasmacytic cells | 1.31 (1.1-1.5) | < .001 |
| Hemoglobin value | 0.7 (0.5-0.9) | .002 |
| Serum M protein value | 2.1 (1.3-3.5) | .003 |
| IgA reduction | 2.4 (1.1-5.4) | .036 |
| Multivariate model . | Hazard ratio . | P . |
|---|---|---|
| Bone marrow lymphoplasmacytic cells | 1.31 (1.1-1.5) | < .001 |
| Hemoglobin value | 0.7 (0.5-0.9) | .002 |
| Serum M protein value | 2.1 (1.3-3.5) | .003 |
| IgA reduction | 2.4 (1.1-5.4) | .036 |